Residency · Chicago, IL
Sponsored by University of Chicago Medical Center
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
The New England journal of medicine · 2022 · 2,432 citations · Everett E. Vokes
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · Aditya Juloori
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.
The New England journal of medicine · 2023 · 1,050 citations · Everett E. Vokes
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 159 citations · Aditya Juloori, Loren Mell
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 456 citations · Loren Mell
Readability of Patient Education Materials From High-Impact Medical Journals: A 20-Year Analysis.
Journal of patient experience · 2021 · 318 citations ·
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 561 citations · Everett E. Vokes
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 323 citations · Loren Mell